XTL BIOPHARMACEUTICALS LTD (XTLB) Form 8-K Material Events
XTL BIOPHARMACEUTICALS LTD (XTLB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XTLB
CIK: 1023549
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Barzily&Co Certified Public Accountants
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJonathan Steinberger
Audit LocationJerusalem, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-14 | 2026-10-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-109415 | View SEC Doc Filr Page |
| 6-K | 2026-08-05 | 2026-08-05 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-085693 | View SEC Doc Filr Page |
| 6-K | 2026-07-21 | 2026-07-21 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-080006 | View SEC Doc Filr Page |
| 20-F | 2026-06-30 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-073831 | View SEC Doc Filr Page |
| 6-K | 2026-06-30 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-073813 | View SEC Doc Filr Page |
| 6-K | 2026-06-29 | 2026-06-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-073158 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-070771 | View SEC Doc Filr Page |
| 6-K | 2026-05-22 | 2026-05-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-060565 | View SEC Doc Filr Page |
| 6-K | 2026-05-15 | 2026-05-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-057942 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-053067 | View SEC Doc Filr Page |
| NT 20-F | 2026-04-30 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-050305 | View SEC Doc Filr Page |
| 6-K | 2026-04-29 | 2026-04-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-048875 | View SEC Doc Filr Page |
| 3 | 2026-03-23 | 2026-03-18 | 3 Filing | 0001213900-26-032909 | View SEC Doc Filr Page |
| 3 | 2026-03-23 | 2026-03-18 | 3 Filing | 0001213900-26-032911 | View SEC Doc Filr Page |
| 6-K | 2026-03-20 | 2026-03-20 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-032348 | View SEC Doc Filr Page |
| 6-K | 2026-03-10 | 2026-03-10 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-025691 | View SEC Doc Filr Page |
| 6-K | 2026-02-27 | 2026-02-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-021691 | View SEC Doc Filr Page |
| 6-K | 2026-02-24 | 2026-02-24 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-019877 | View SEC Doc Filr Page |
| 6-K | 2026-02-23 | 2026-02-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-019324 | View SEC Doc Filr Page |
| 6-K | 2026-02-17 | 2026-02-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-017282 | View SEC Doc Filr Page |
| 6-K | 2026-01-28 | 2026-01-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-008572 | View SEC Doc Filr Page |
| 6-K | 2026-01-23 | 2026-01-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-007213 | View SEC Doc Filr Page |
| 6-K | 2026-01-23 | 2026-01-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-007212 | View SEC Doc Filr Page |
| 6-K | 2026-01-13 | 2026-01-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-003911 | View SEC Doc Filr Page |
| 6-K | 2026-01-13 | 2026-01-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-003672 | View SEC Doc Filr Page |